XML 49 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Operating activities:      
Net income $ 46,625,000 $ 48,429,000 $ 29,660,000
Adjustments to reconcile net income to net cash provided by (used for) operating activities:      
Depreciation and amortization 45,945,000 41,947,000 41,924,000
Deferred income taxes and related valuation allowance (15,285,000) (300,000) (1,969,000)
Net loss (gain) on sale of real estate, investments and other (1,431,000) (54,000) 136,000
Stock-based compensation 12,039,000 10,425,000 11,246,000
Amortization of deferred financing costs 2,349,000 1,721,000 1,703,000
Loss (gain) on hedging instruments (1,366,000) (438,000) 853,000
Cost of debt refinancing 0 0 14,803,000
Cost of debt repricing 958,000 0 0
Loss on retirement of fixed asset 0 175,000 0
Non-cash pension settlement expense (See Note 13) 4,984,000 0 0
Gain on sale of building (See Note 3) 0 (232,000) (375,000)
Non-cash lease expense 9,735,000 7,867,000 7,945,000
Changes in operating assets and liabilities, net of effects of business acquisitions and divestitures:      
Trade accounts receivable (14,428,000) (4,858,000) (18,988,000)
Inventories (1,314,000) (9,087,000) (40,201,000)
Prepaid expenses and other (8,555,000) 6,667,000 (47,000)
Other assets 537,000 (123,000) 25,000
Trade accounts payable 4,748,000 (13,964,000) 12,681,000
Accrued liabilities (9,583,000) 9,150,000 696,000
Non-current liabilities (8,760,000) (13,689,000) (11,211,000)
Net cash provided by (used for) operating activities 67,198,000 83,636,000 48,881,000
Investing activities:      
Proceeds from sales of marketable securities 3,526,000 3,651,000 4,434,000
Purchases of marketable securities (4,076,000) (4,021,000) (7,130,000)
Capital expenditures (24,813,000) (12,632,000) (13,104,000)
Proceeds from sale of building, net of transaction costs 0 373,000 461,000
Proceeds from insurance reimbursement 0 0 482,000
Dividend received from equity method investment 144,000 313,000 324,000
Purchase of businesses, net of cash acquired (See Note 3) (108,145,000) (1,616,000) (539,778,000)
Net cash provided by (used for) investing activities (133,364,000) (13,932,000) (554,311,000)
Financing activities:      
Proceeds from issuance of common stock 1,600,000 713,000 2,655,000
Fees paid for debt repricing (958,000) 0 0
Purchases of treasury stock 0 (1,001,000) 0
Repayment of debt (60,604,000) (40,550,000) (477,846,000)
Fees paid for borrowing on long-term debt (2,859,000) 0 0
Proceeds from issuance of long-term debt 120,000,000 0 725,000,000
Proceeds from equity offering 0 0 207,000,000
Fees related to debt and equity offering 0 0 (26,184,000)
Cash inflows from hedging activities 24,057,000 24,495,000 19,417,000
Cash outflows from hedging activities (22,687,000) (24,221,000) (20,206,000)
Payment of dividends (8,044,000) (8,008,000) (6,562,000)
Other (2,304,000) (1,415,000) (2,574,000)
Net cash provided by (used for) financing activities 48,201,000 (49,987,000) 420,700,000
Effect of exchange rate changes on cash (1,085,000) (1,931,000) (2,007,000)
Net change in cash and cash equivalents (19,050,000) 17,786,000 (86,737,000)
Cash, cash equivalents, and restricted cash at beginning of year 133,426,000 115,640,000 202,377,000
Cash, cash equivalents, and restricted cash at end of year 114,376,000 133,426,000 115,640,000
Supplementary cash flows data:      
Interest paid 34,983,000 26,089,000 18,823,000
Income taxes paid, net of refunds 28,369,000 22,032,000 9,767,000
Property, plant and equipment purchases included in trade accounts payable 690,000 624,000 329,000
Restricted cash presented in Other assets $ 250,000 $ 250,000 $ 250,000